Laborie Medical Technologies Invests in Bright Uro’s Innovative Wireless Urodynamic System

Follow Bollyinside on Google News

Must Read

― Advertisement ―

Laborie Medical Technologies Invests in Medical Technology Start-Up Bright Uro

  • Laborie Medical Technologies Corp. has made a strategic equity investment in Bright Uro, an early-stage medical technology company focused on transforming care for lower urinary tract symptoms (LUTS).
  • Bright Uro is developing the Glean Urodynamic System, a wireless, catheter-free, urodynamic monitoring system designed to improve patient comfort and clinical outcomes for those suffering from LUTS.
  • Laborie’s investment in Bright Uro aligns with its commitment to providing world-class diagnostic and therapeutic care in Urology, leveraging its expertise and leadership in the global urodynamics market to support the innovative technology developed by Bright Uro.
  • The investment is backed by Patricia Industries, a long-term owner that invests in companies and works to develop each company to its full potential, signaling a strong partnership and support for the growth and success of Bright Uro.
  • Laborie’s Commitment to Transforming Care for LUTS

    Laborie Medical Technologies Corp. has announced a strategic equity investment in Bright Uro, an early-stage medical technology company focused on transforming care for lower urinary tract symptoms (LUTS). The investment in Bright Uro’s innovative Glean Urodynamic System aligns with Laborie’s commitment to providing world-class diagnostic and therapeutic care in Urology. This strategic partnership allows Laborie to leverage its expertise and leadership in the global urodynamics market to support the development and implementation of the wireless, catheter-free urodynamic monitoring system, ultimately improving patient access and outcomes.

    Bright Uro’s Innovative Technology for Improved Patient Comfort

    Bright Uro is developing the Glean Urodynamic System, a wireless, catheter-free, urodynamic monitoring system intended to quantify the pressure characteristics of the lower urinary tract. This innovative technology aims to disrupt outdated urodynamics approaches, enabling wireless, catheter-free urodynamics monitoring with the ultimate goal of improving patient comfort and clinical outcomes. The Glean system is designed to provide a more comfortable and convenient experience for patients undergoing urodynamic testing, addressing the needs of individuals suffering from LUTS.

    Patricia Industries’ Support for Growth and Development

    The investment in Bright Uro by Laborie Medical Technologies is backed by Patricia Industries, a long-term owner that invests in companies and works to develop each company to its full potential. This partnership signals strong support for the growth and success of Bright Uro, highlighting the commitment to providing patients and clinicians with innovative tools that elevate the standard of care. The collaboration between Laborie, Bright Uro, and Patricia Industries sets the stage for advancements in urodynamic monitoring technology and improved care for individuals with lower urinary tract symptoms.

    Source Credit

    Photo Credit: b2491169.smushcdn.com

    Read More

    Latest Today